Category: BioMimetic Therapeutics Inc.Syndicate content

Appeals court upholds dismissal in BioMimetic shareholder lawsuit

April 2, 2014 by Brad Perriello

A federal appeals court upholds the dismissal of a lawsuit brought by shareholders of BioMimetic Therapeutics, acquired by Wright Medical in 2012.

Appeals court upholds dismissal in BioMimetic shareholder lawsuit

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Pessimistic Wright Medical wins FDA date for Augment

February 25, 2014 by Brad Perriello

Wright Medical says it's not optimistic about an FDA dispute resolution panel this May on its Augment biologic bone graft.

Pessimistic Wright Medical wins FDA date for Augment

Wright Medical (NSDQ:WMGI) said it's not optimistic about an FDA dispute resolution panel on its Augment biologic bone graft product, now slated for May, and would quickly move to cut costs at the BioMimetic Therapeutics subsidiary it bought back in 2012.

Wright Medical dives on non-approvable letter for Augment bone graft

August 9, 2013 by Brad Perriello

Wright Medical shares take a dive after it reveals a non-approvable letter from the FDA for the Augment bone graft it acquired along with BioMimetic Therapeutics last year.

Wright Medical dives on non-approvable letter for Augment bone putty

Wright Medical (NSDQ:WMGI) shares are down nearly 9% today after the medical device company revealed that the FDA won't approve its Augment bone graft.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Device tax will "absolutely, directly, negatively influence job growth" | MassDevice.com On Call

January 23, 2013 by MassDevice staff

The medical device tax will have an inevitably negative effect on jobs in the medtech industry, BioMimetic Therapeutics founder Sam Lynch says.

MassDevice On Call

MASSDEVICE ON CALL — The 1st payments for the 2.3% medical device tax which took effect this year are due at the end of the month, and the burden of those new fees will "absolutely, directly, negatively influence job growth," BioMimetic Therapeutics founder Sam Lynch told reporters.

Wright Medical's back on track, eager to close BioMimetic buyout

January 8, 2013 by Arezu Sarvestani

Orthopedic medical device maker Wright Medical's company-wide overhaul is on or ahead of schedule in most areas, and the company is looking forward to closing the $390 million buyout of BioMimetic Therapeutics.

Wright Medical Group logo

Orthopedic giant Wright Medical (NSDQ:WMGI) is back on track, CEO Robert Palmisano told an audience at the J.P. Morgan Healthcare conference in San Francisco yesterday.

Wright Medical begins buying up BioMimetic shares

November 30, 2012 by MassDevice staff

Wright Medical Group picks up about 10 million shares of BioMimetic Therapeutics, for about a 36% stake, ahead of its planned merger next year.

Wright Medical begins BioMimetic Therapeutics merger

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp